Skip to main content
. 2020 Jan 13;43(3):807–816. doi: 10.3892/or.2020.7459

Figure 5.

Figure 5.

CVB-D induces apoptosis of T98G and Hs683 cells. (A) Apoptotic analysis was performed by flow cytometry. (B) Statistical analysis of the percentages of apoptotic cells following treatment with various concentrations of CVB-D. Each treatment dosing group was compared with the control group. *P<0.05, ***P<0.001, ****P<0.0001. Survival: PI/Annexin V; early apoptosis: PI/Annexin V+; late apoptosis: PI+/Annexin V+. Each experiment involved three replicates. CVB-D, Cyclovirobuxine D.